Marco Alvarez Arrazola
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Marco Alvarez Arrazola has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Eliakym Arámbula-Meraz
Laboratorio de Genética y Biología Molecular, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Sinaloa, Culiacán 80010, Mexico
2 shared publications - Fred Luque-Ortega
Laboratorio de Ciencias Básicas, Facultad de Odontología, Universidad Autónoma de Sinaloa, C. Josefa Ortiz de Domínguez s/n, Cd. Universitaria, Culiacán Rosales 80013, Mexico
2 shared publications - Noemí García-Magallanes
Laboratorio de Biomedicina y Biología Molecular, Ingeniería en Biotecnología, Universidad Politécnica de Sinaloa, Mazatlán, 82199, Mexico
2 shared publications - Adrián González-Castillo
Programa Académico de Ingeniería en Biotecnología, Laboratorio de Bioinformática Microbiana, Universidad Politécnica de Sinaloa, Mazatlán, Mexico
1 shared publication - Alejandra Martínez-Camberos
Unidad Regional Mazatlán, Laboratorio de Investigación Biomédica y Biotecnológica, Universidad Autónoma de Occidente, Av. del Mar 1200, Col. Tellería, Mazatlán C.P. 82100, Sinaloa, Mexico
1 shared publication - Dora Maria Cedano-Prieto
Facultad de Ciencias Químico-Biológicas, Universidad Autónoma de Sinaloa, Culiacán 80010, Sinaloa, Mexico
1 shared publication
Latest Publications
- Open Access
- 22 September 2025
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (9) , 782
miR-145-5p and miR-148b-3p Expression Is Inversely Associated with Pten Expression in Prostate Pathologies
Prostate cancer (PCa) represents a significant cause of cancer-associated mortality in the male population worldwide and constitutes a multifactorial disease influenced by genetic and epigenetic factors. Deregulation of genes such as AR and PTEN, as well as alteration in the expression of microRNAs (miRNAs), including miR-145-5p and miR-148b-3p, has been observed in this pathology. This study aimed to explore the correlation between the expression of miR-145-5p, miR-148b-3p, and PTEN in prostate tissue, providing initial insight into their potential interaction in cancer biology. We analyzed 71 samples, comprising 41 from patients with confirmed prostate cancer (PCa group) and 30 from patients with benign prostatic disease (BPD group). Our findings demonstrated a statistically significant association between both miRNAs and the PTEN gene, specifically between miR-148b-3p and PTEN (p = 0.00001) and between miR-145-5p and PTEN (p = 0.0078). These findings support the hypothesis that reduced levels of these miRNAs may be linked to PTEN regulation in prostate pathologies and underscore their potential relevance in PCa biology.
- 22 September 2025
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (9) , 782
Open AccessmiR-145-5p and miR-148b-3p Expression Is Inversely Associated with Pten Expression in Prostate Pathologies
Prostate cancer (PCa) represents a significant cause of cancer-associated mortality in the male population worldwide and constitutes a multifactorial disease influenced by genetic and epigenetic factors. Deregulation of genes such as AR and PTEN, as well as alteration in the expression of microRNAs (miRNAs), including miR-145-5p and miR-148b-3p, has been observed in this pathology. This study aimed to explore the correlation between the expression of miR-145-5p, miR-148b-3p, and PTEN in prostate tissue, providing initial insight into their potential interaction in cancer biology. We analyzed 71 samples, comprising 41 from patients with confirmed prostate cancer (PCa group) and 30 from patients with benign prostatic disease (BPD group). Our findings demonstrated a statistically significant association between both miRNAs and the PTEN gene, specifically between miR-148b-3p and PTEN (p = 0.00001) and between miR-145-5p and PTEN (p = 0.0078). These findings support the hypothesis that reduced levels of these miRNAs may be linked to PTEN regulation in prostate pathologies and underscore their potential relevance in PCa biology.
- 31 May 2022
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 617 (Pt 1) , 55-59
Dysregulation of KRT19, TIMP1, and CLDN1 gene expression is associated with thyroid cancer
- 31 May 2022
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 617 (Pt 1) , 55-59
Dysregulation of KRT19, TIMP1, and CLDN1 gene expression is associated with thyroid cancer